
11062020 US Pre Open
The S&P 500 Futures are on the downside after the Federal Reserve hinted at keeping interest rates near zero through 2022.
Share this:
Later today Producer Price Index (+0.1% on month in May expected), Initial Jobless Claims (a fall to 1.550 million expected) and Continuing Claims (a fall to 20.000 million expected) will be published.
European indices are under pressure. In the U.K., the RICS index measuring house prices came out at -32% in May, against -24% expected and -22% the previous month (revised from -21%).
Asian indices closed deeply in the red. This morning, government data showed that Japan's first quarter BSI All Industry Business Condition Index for large firms sank to -47.6 (-38.4 expected) from -10.1 in the prior quarter. Official data showed that China's M2 money supply rose 11.1% on year in May (+11.3% expected), while new yuan loans totaled 1,480 billion yuan (1,600 billion yuan expected).
WTI Crude Oil Futures are falling. U.S. Energy Information Administration's weekly has reported that the country's crude-oil stockpiles rose to a record level of 538.1 million barrels.
Gold is edging lower on profit taking following a bounce after the Fed decision. Gold fell 12.21 dollars (-0.7%) to 1726.49 dollars.
The US dollar gains ground on falling equities. EUR/USD fell 16pips to 1.1358. GBP/USD dropped 88pips to 1.2659 on Brexit concerns.
US Equity Snapshot
Amazon.com (AMZN): the European Union plans to issue formal antitrust charges against the e-commerce giant, according to Dow Jones Newswires.
Grubhub (GRUB) and Just Eat Takeaway.com have entered into a definitive agreement whereby Just Eat Takeaway.com is to acquire 100% of the shares of Grubhub in an all-stock transaction "to create a leading global online food delivery player". The transaction represents an implied value of 75.15 dollars for each Grubhub share and implies a total equity consideration of 7.3 billion dollars.
Delta Airlines (DAL) forecasts second quarter sales to be down 90% with a systemwide capacity down 85%. The company expects to reduce its average daily cash outflow to approximately 40 million dollars by June 30, 2020, down from approximately 100 million dollars per day as of March 31, 2020.
Regeneron (REGN), the pharma company, announced "the initiation of clinical trials for its investigational anti-viral antibody cocktail for the treatment and prevention of COVID-19".
Source : TradingVIEW, Gain Capital
Latest market news
View more newsThe complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

S&P 500, Nasdaq, Dow Forecast: Rising Yields Test Rally Ahead of Nvidia, Fed 8 22 2026
S&P 500, Nasdaq and Dow test key technical levels as momentum fades, raising the risk of a deeper correction heading into a pivotal week.

Magnificent Seven Earnings Preview: Can Big Tech Reclaim AI Leadership?
The Magnificent Seven enter earnings with far more divided performance than in previous years, as investors increasingly distinguish between companies supplying the AI buildout and those funding it - what does that mean heading into earnings season?

USD/JPY unwind accelerates as GPIF headlines spark yen buying
Japanese assets are rallying after the government floated the prospect of the GPIF investing more heavily at home. While the proposal could have significant implications for global capital flows, it does not yet change the broader forces driving Japanese bond yields and USD/JPY.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.








